Investors

Facts by State

Better Investing

CVS Caremark is a Corporate Member of Better Investing (formerly NAIC) and participates in its Low-Cost Investment Plan. To receive more information on Better Investing, call (248) 583-NAIC or visit their website by clicking here.

CVS Caremark is the only fully integrated pharmacy health care company in the United States.  Our offerings across the entire spectrum of pharmacy care allow us to provide greater convenience and choice for patients, improve health outcomes, and lower overall health care costs for plan sponsors and participants.  As one of the country’s largest pharmacy benefit managers (PBMs), we provide plan sponsors and participants access to a network of approximately 60,000 pharmacies including over 7,000 CVS/pharmacy stores.  CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and our clinical expertise includes one of the industry’s most comprehensive disease management programs.  We are also a leading provider of Medicare Part D Prescription Drug Plans.Learn more

Recent news

11-05-2009
David Denton to Become CVS Caremark Chief Financial Officer

Denton replaces David Rickard who retires at year end Laird Daniels named Controller and Chief Accounting Officer WOONSOCKET, R.I.--(BUSINESS WIRE)--Nov. 5, 2009-- CVS Caremark (NYSE: CVS) today announced the appointment of David M. Denton to the new role of Executive Vice President and Chief Financial Officer, effective January 1, 2010. Denton will succeed David Rickard who announced in February of this year his intention to retire a
11-05-2009
CVS Caremark Corporation Announces New Authorization of Repurchase Program for up to $2 Billion of Common Stock

WOONSOCKET, R.I.--(BUSINESS WIRE)--Nov. 5, 2009-- CVS Caremark Corporation (NYSE: CVS) today announced that its Board of Directors has approved a new share repurchase program for up to $2.0 billion of its outstanding common stock. The share repurchase authorization, which is effective immediately and expires at the end of 2011, permits the Company to effect the repurchases from time to time through a combination of open market repurchases, privately
11-05-2009
CVS Caremark Reports Record Third Quarter 2009 Results

Third Quarter Year-Over-Year Highlights: Adjusted EPS from continuing operations of $0.65 (excluding an $0.11 income tax benefit), up 8.1% GAAP diluted EPS from continuing operations of $0.71 (including an $0.11 income tax benefit) Net revenues of $24.6 billion, up 18.1% PBM revenues increased 23.4%, with pharmacy network revenues up 28.3% while mail choice reven
View All

Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.